Although the vast majority of PPH cases in the included studies were controlled with uterotonics (primarily oxytocin), providers seemed impressed and reassured by the capacity of a relatively simple device to arrest blood loss. This evidence concerns the gene OXT and pulmonary arterial hypertension.